{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T00:45:54Z","timestamp":1760489154665,"version":"build-2065373602"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,14]],"date-time":"2025-10-14T00:00:00Z","timestamp":1760400000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,14]],"date-time":"2025-10-14T00:00:00Z","timestamp":1760400000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Adv Rheumatol"],"DOI":"10.1186\/s42358-025-00477-0","type":"journal-article","created":{"date-parts":[[2025,10,14]],"date-time":"2025-10-14T12:05:09Z","timestamp":1760443509000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Cytokine-induced memory-like natural killer cells in systemic lupus erythematosus patients"],"prefix":"10.1186","volume":"65","author":[{"given":"Chien-Ya","family":"Hsu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yen-Chang","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hsiu-Shan","family":"Hsiao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pei-Tzu","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ji-Yih","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Syh-Jae","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,10,14]]},"reference":[{"issue":"7","key":"477_CR1","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1080\/08916930500285394","volume":"38","author":"P Sarzi-Puttini","year":"2005","unstructured":"Sarzi-Puttini P, Atzeni F, Iaccarino L, Doria A. Environment and systemic lupus erythematosus: an overview. Autoimmunity. 2005;38(7):465\u201372.","journal-title":"Autoimmunity"},{"issue":"4","key":"477_CR2","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1189\/jlb.4RU0315-081RR","volume":"98","author":"R Spada","year":"2015","unstructured":"Spada R, Rojas JM, Barber DF. Recent findings on the role of natural killer cells in the pathogenesis of systemic lupus erythematosus. J Leukoc Biol. 2015;98(4):479\u201387.","journal-title":"J Leukoc Biol"},{"key":"477_CR3","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1007\/s10067-013-2176-8","volume":"32","author":"A Henriques","year":"2013","unstructured":"Henriques A, Teixeira L, In\u00eas L, Carvalheiro T, Gon\u00e7alves A, Martinho A, et al. NK cells dysfunction in systemic lupus erythematosus: relation to disease activity. Clin Rheumatol. 2013;32:805\u201313.","journal-title":"Clin rheumatol"},{"key":"477_CR4","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.jaut.2012.12.009","volume":"42","author":"S Bernatsky","year":"2013","unstructured":"Bernatsky S, Ramsey-Goldman R, Labrecque J, Joseph L, Boivin J-F, Petri M, et al. Cancer risk in systemic lupus: an updated international multi-centre cohort study. J Autoimmun. 2013;42:130\u201335.","journal-title":"J autoimmun"},{"issue":"1","key":"477_CR5","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1084\/jem.20082013","volume":"206","author":"ND Huntington","year":"2009","unstructured":"Huntington ND, Legrand N, Alves NL, Jaron B, Weijer K, Plet A, et al. IL-15 trans-presentation promotes human NK cell development and differentiation in vivo. J Exp Med. 2009;206(1):25\u201334.","journal-title":"J Exp Med"},{"issue":"12","key":"477_CR6","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.1084\/jem.20020369","volume":"195","author":"TC Becker","year":"2002","unstructured":"Becker TC, Wherry EJ, Boone D, Murali-Krishna K, Antia R, Ma A, Ahmed R. Interleukin 15 is required for proliferative renewal of virus-specific memory CD8 T cells. J Exp Med. 2002;195(12):1541\u201348.","journal-title":"J Exp Med"},{"issue":"8","key":"477_CR7","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1093\/rheumatology\/40.8.876","volume":"40","author":"M Aringer","year":"2001","unstructured":"Aringer M, Stummvoll G, Steiner G, K\u00f6ller M, Steiner C, H\u00f6fler E, et al. Serum interleukin-15 is elevated in systemic lupus erythematosus. Rheumatology. 2001;40(8):876\u201381.","journal-title":"Rheumatology"},{"issue":"12","key":"477_CR8","doi-asserted-by":"publisher","first-page":"1507","DOI":"10.1093\/rheumatology\/kei083","volume":"44","author":"L Baranda","year":"2005","unstructured":"Baranda L, De La Fuente H, Layseca-Espinosa E, Portales-Perez D, Nino-Moreno P, Valencia-Pacheco G, et al. IL-15 and IL-15R in leucocytes from patients with systemic lupus erythematosus. Rheumatology. 2005;44(12):1507\u201313.","journal-title":"Rheumatology"},{"key":"477_CR9","doi-asserted-by":"crossref","unstructured":"Lin S-J, Kuo M-L, Hsiao H-S, Lee P-T, Lee W-I, Chen J-Y, Huang J-L. Cytotoxic function and cytokine production of natural killer cells and natural killer T-like cells in systemic lupus erythematosis regulation with interleukin-15. Mediators Inflamm. 2019;2019:4236562.","DOI":"10.1155\/2019\/4236562"},{"issue":"10","key":"477_CR10","doi-asserted-by":"publisher","first-page":"e0186223","DOI":"10.1371\/journal.pone.0186223","volume":"12","author":"S-J Lin","year":"2017","unstructured":"Lin S-J, Kuo M-L, Hsiao H-S, Lee P-T, Chen J-Y, Huang J-L. Activating and inhibitory receptors on natural killer cells in patients with systemic lupus erythematosis-regulation with interleukin-15. PLoS One. 2017;12(10):e0186223.","journal-title":"PLoS One"},{"key":"477_CR11","doi-asserted-by":"crossref","unstructured":"Lin S-J, Chen J-Y, Kuo M-L, Hsiao H-S, Lee P-T, Huang J-L. Effect of interleukin-15 on CD11b, CD54, and CD62L expression on natural killer cell and natural killer T-like cells in systemic lupus erythematosus. Mediators Inflamm. 2016;2016:9675861.","DOI":"10.1155\/2016\/9675861"},{"issue":"6","key":"477_CR12","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1159\/000382019","volume":"7","author":"MM Berrien-Elliott","year":"2015","unstructured":"Berrien-Elliott MM, Wagner JA, Fehniger TA. Human cytokine-induced memory-like natural killer cells. J Innate Immun. 2015;7(6):563\u201371.","journal-title":"J Innate Immun"},{"issue":"4","key":"477_CR13","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1016\/j.bbmt.2014.01.006","volume":"20","author":"JW Leong","year":"2014","unstructured":"Leong JW, Chase JM, Romee R, Schneider SE, Sullivan RP, Cooper MA, Fehniger TA. Preactivation with IL-12, IL-15, and IL-18 induces CD25 and a functional high-affinity IL-2 receptor on human cytokine-induced memory-like natural killer cells. Biol Blood Marrow transplant. 2014;20(4):463\u201373.","journal-title":"Biol Blood Marrow transplant"},{"issue":"1","key":"477_CR14","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.ygyno.2019.01.006","volume":"153","author":"LD Uppendahl","year":"2019","unstructured":"Uppendahl LD, Felices M, Bendzick L, Ryan C, Kodal B, Hinderlie P, et al. Cytokine-induced memory-like natural killer cells have enhanced function, proliferation, and in vivo expansion against ovarian cancer cells. Gynecol Oncol. 2019;153(1):149\u201357.","journal-title":"Gynecol Oncol"},{"issue":"357","key":"477_CR15","doi-asserted-by":"publisher","first-page":"357ra123","DOI":"10.1126\/scitranslmed.aaf2341","volume":"8","author":"R Romee","year":"2016","unstructured":"Romee R, Rosario M, Berrien-Elliott MM, Wagner JA, Jewell BA, Schappe T, et al. Cytokine-induced memory-like natural killer cells exhibit enhanced responses against myeloid leukemia. Sci Transl Med. 2016;8(357):357ra123.","journal-title":"Sci Transl Med"},{"issue":"1","key":"477_CR16","doi-asserted-by":"publisher","first-page":"5858","DOI":"10.1038\/s41598-020-62654-z","volume":"10","author":"S-J Lin","year":"2020","unstructured":"Lin S-J, Hsu C-Y, Kuo M-L, Lee P-T, Hsiao H-S, Chen J-Y. Phenotypic and functional characterization of natural killer cells in rheumatoid arthritis-regulation with interleukin-15. Sci Rep. 2020;10(1):5858.","journal-title":"Sci Rep"},{"issue":"1","key":"477_CR17","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1046\/j.0905-6157.2003.00103.x","volume":"15","author":"S-J Lin","year":"2004","unstructured":"Lin S-J, Cheng P-J, Huang Y-J, Kuo M-L. Evaluation of cytotoxic function and apoptosis in interleukin (IL)-12\/IL-15-treated umbilical cord or adult peripheral blood natural killer cells by a propidium-iodide based flow cytometry. Pediatr Allergy Immunol. 2004;15(1):79\u201385.","journal-title":"Pediatr Allergy Immunol"},{"issue":"8","key":"477_CR18","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1093\/rheumatology\/40.8.876","volume":"40","author":"M Aringer","year":"2001","unstructured":"Aringer M, Stummvoll GH, Steiner G, K\u00f6ller M, Steiner CW, H\u00f6fler E, et al. Serum interleukin-15 is elevated in systemic lupus erythematosus. Rheumatology. 2001;40(8):876\u201381.","journal-title":"Rheumatology"},{"key":"477_CR19","doi-asserted-by":"crossref","unstructured":"Schwane V, Huynh-Tran VH, Vollmers S, Yakup VM, Sauter J, Schmidt AH, et al. Distinct signatures in the receptor repertoire discriminate CD56bright and CD56dim natural killer cells. Front Immunol. 2020;11:568927.","DOI":"10.3389\/fimmu.2020.568927"},{"issue":"1","key":"477_CR20","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1111\/j.1365-2567.2008.02887.x","volume":"126","author":"D Schepis","year":"2009","unstructured":"Schepis D, Gunnarsson I, Eloranta ML, Lampa J, Jacobson SH, K\u00e4rre K, Berg L. Increased proportion of CD56bright natural killer cells in active and inactive systemic lupus erythematosus. Immunology. 2009;126(1):140\u201346.","journal-title":"Immunology"},{"issue":"7","key":"477_CR21","doi-asserted-by":"publisher","first-page":"2923","DOI":"10.4049\/jimmunol.1502570","volume":"196","author":"T Michel","year":"2016","unstructured":"Michel T, Poli A, Cuapio A, Briquemont B, Iserentant G, Ollert M, Zimmer J. Human CD56bright NK cells: an update. The J Immunol. 2016;196(7):2923\u201331.","journal-title":"The J Immunol"},{"issue":"3","key":"477_CR22","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.it.2004.12.006","volume":"26","author":"D Sancho","year":"2005","unstructured":"Sancho D, G\u00f3mez M, S\u00e1nchez-Madrid F. CD69 is an immunoregulatory molecule induced following activation. Trends Immunol. 2005;26(3):136\u201340.","journal-title":"Trends Immunol"},{"issue":"6","key":"477_CR23","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1002\/eji.201646837","volume":"47","author":"D Cibri\u00e1n","year":"2017","unstructured":"Cibri\u00e1n D, S\u00e1nchez-Madrid F. CD69: from activation marker to metabolic gatekeeper. Eur. J. Immunol. 2017;47(6):946\u201353.","journal-title":"Eur. J. Immunol"},{"key":"477_CR24","doi-asserted-by":"crossref","unstructured":"Hudspeth K, Silva-Santos B, Mavilio D. Natural cytotoxicity receptors: broader expression patterns and functions in innate and adaptive immune cells. Front Immunol. 2013;4:69.","DOI":"10.3389\/fimmu.2013.00069"},{"key":"477_CR25","doi-asserted-by":"crossref","unstructured":"Parodi M, Favoreel H, Candiano G, Gaggero S, Sivori S, Mingari MC, et al. NKp44-NKp44 ligand interactions in the regulation of natural killer cells and other innate lymphoid cells in humans. Front Immunol. 2019;10:719.","DOI":"10.3389\/fimmu.2019.00719"},{"issue":"1","key":"477_CR26","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1034\/j.1600-065X.2003.00044.x","volume":"193","author":"SJ Lord","year":"2003","unstructured":"Lord SJ, Rajotte RV, Korbutt GS, Bleackley RC. Granzyme B: a natural born killer. Immunol Rev. 2003;193(1):31\u201338.","journal-title":"Immunol Rev"},{"issue":"1","key":"477_CR27","doi-asserted-by":"publisher","first-page":"109","DOI":"10.5114\/ceji.2014.42135","volume":"39","author":"I Osi\u0144ska","year":"2014","unstructured":"Osi\u0144ska I, Popko K, Demkow U. Perforin: an important player in immune response. Cent Eur J Immunol. 2014;39(1):109\u201315.","journal-title":"Cent Eur J Immunol"},{"issue":"6","key":"477_CR28","doi-asserted-by":"publisher","first-page":"1753","DOI":"10.1002\/art.24556","volume":"60","author":"YW Park","year":"2009","unstructured":"Park YW, Kee SJ, Cho YN, Lee EH, Lee HY, Kim EM, et al. Impaired differentiation and cytotoxicity of natural killer cells in systemic lupus erythematosus. Arthritis Rheum. 2009;60(6):1753\u201363.","journal-title":"Arthritis Rheum"},{"key":"477_CR29","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1007\/978-1-4939-8885-3_7","volume-title":"Cancer immunosurveillance: methods and protocols","author":"S Lorenzo-Herrero","year":"2019","unstructured":"Lorenzo-Herrero S, Sordo-Bahamonde C, Gonzalez S, L\u00f3pez-Soto A. CD107a degranulation assay to evaluate immune cell antitumor activity. In: L\u00f3pez-Soto A, Folgueras A, editors. Cancer immunosurveillance: methods and protocols. New York, NY: Springer New York; 2019. p. 119\u201330."},{"issue":"6","key":"477_CR30","doi-asserted-by":"publisher","first-page":"1698","DOI":"10.1002\/art.30313","volume":"63","author":"B Hervier","year":"2011","unstructured":"Hervier B, Beziat V, Haroche J, Mathian A, Lebon P, Ghillani-Dalbin P, et al. Phenotype and function of natural killer cells in systemic lupus erythematosus: excess interferon-\u03b3 production in patients with active disease. Arthritis Rheum. 2011;63(6):1698\u2013706.","journal-title":"Arthritis Rheum"},{"key":"477_CR31","first-page":"185","volume-title":"Semin Hematol: 2020","author":"M Gang","year":"2020","unstructured":"Gang M, Wong P, Berrien-Elliott MM, Fehniger TA. Memory-like natural killer cells for cancer immunotherapy. In: Semin Hematol: 2020. Elsevier; 2020. p. 185\u201393."},{"issue":"4","key":"477_CR32","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1002\/art.1780400424","volume":"40","author":"L Mellemkj\u00e9r","year":"1997","unstructured":"Mellemkj\u00e9r L, Andersen V, Linet MS, Gridley G, Hoover R, Olsen JH. Non-Hodgkin\u2019s lymphoma and other cancers among a cohort of patients with systemic lupus erythematosus. Arthritis Rheum. 1997;40(4):761\u201368.","journal-title":"Arthritis Rheum"},{"issue":"6","key":"477_CR33","doi-asserted-by":"publisher","first-page":"805","DOI":"10.3324\/haematol.2011.056283","volume":"97","author":"SM Ramadan","year":"2012","unstructured":"Ramadan SM, Fouad TM, Summa V, Hasan SK, Lo-Coco F. Acute myeloid leukemia developing in patients with autoimmune diseases. Haematologica. 2012;97(6):805.","journal-title":"Haematologica"}],"container-title":["Advances in Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s42358-025-00477-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s42358-025-00477-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s42358-025-00477-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T00:02:41Z","timestamp":1760486561000},"score":1,"resource":{"primary":{"URL":"https:\/\/advancesinrheumatology.biomedcentral.com\/articles\/10.1186\/s42358-025-00477-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,14]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["477"],"URL":"https:\/\/doi.org\/10.1186\/s42358-025-00477-0","relation":{},"ISSN":["2523-3106"],"issn-type":[{"type":"electronic","value":"2523-3106"}],"subject":[],"published":{"date-parts":[[2025,10,14]]},"assertion":[{"value":"16 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All experimental protocols were approved by the Chang Gung Medical Foundation Institutional Review Board (IRB: 201801498A3).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"47"}}